Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.

Szczegóły
Abstrakt

Tytuł:: Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.
Autorzy:: Bonhof CS; CoRPS - Center of Research on Psychological Disorders and Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands. .; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. .
van de Poll-Franse LV; CoRPS - Center of Research on Psychological Disorders and Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
de Hingh IH; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands.; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Vreugdenhil G; Department of Internal Medicine, Máxima Medical Centre, Eindhoven and Veldhoven, The Netherlands.
Mols F; CoRPS - Center of Research on Psychological Disorders and Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Źródło:: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Nov; Vol. 30 (11), pp. 9517-9526. Date of Electronic Publication: 2022 Aug 28.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Berlin : Springer International, c1993-
MeSH Terms:: Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/pathology
Mindfulness*
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/psychology
Humans ; Fatigue/epidemiology ; Patient Reported Outcome Measures ; Severity of Illness Index ; Antineoplastic Agents/adverse effects ; Neoplasm Staging ; Netherlands/epidemiology
References:: Gutiérrez-Gutiérrez G et al (2010) Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol 12(2):81–91. (PMID: 2015677810.1007/S12094-010-0474-z)
Seretny M et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470. (PMID: 2526116210.1016/j.pain.2014.09.020)
Boyette-Davis JA et al (2012) Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res 18(11):3180–3187. (PMID: 22496202361944010.1158/1078-0432.CCR-12-0205)
Bao T et al (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333. (PMID: 27510185550953810.1007/s10549-016-3939-0)
Bonhof CS et al (2019) Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: results from the population-based PROFILES registry. Psychooncology 28(9):1926–1933. (PMID: 31293046677156910.1002/pon.5176)
Hong JS, Tian J, Wu LH (2014) The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Curr Oncol 21(4):174–180. (PMID: 25089099411761510.3747/co.21.1984)
Tofthagen C et al (2013) Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer 21(12):3307–3313. (PMID: 23903798538599910.1007/s00520-013-1905-5)
Bonhof CS et al (2021) Association between peripheral neuropathy and sleep quality among colorectal cancer patients from diagnosis until 2-year follow-up: results from the PROFILES registry. J Cancer Surviv Nov 19. Epub ahead of print.
Loprinzi CL et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO Guideline Update. J Clin Oncol 38(28):3325–3348. (PMID: 3266312010.1200/JCO.20.01399)
Crombez G et al (2012) Fear-avoidance model of chronic pain: the next generation. Clin J Pain 28(6):475–483. (PMID: 2267347910.1097/AJP.0b013e3182385392)
Gatchel RJ et al (2007) The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull 133(4):581–624. (PMID: 1759295710.1037/0033-2909.133.4.581)
Curtin KB, Norris D (2017) The relationship between chronic musculoskeletal pain, anxiety and mindfulness: adjustments to the fear-avoidance model of chronic pain. Scand J Pain 17(1):156–166. (PMID: 2896856710.1016/j.sjpain.2017.08.006)
Park SJ et al (2016) Factors associated with increased risk for pain catastrophizing in patients with chronic neck pain: a retrospective cross-sectional study. Medicine 95(37):e4698. (PMID: 27631217540256010.1097/MD.0000000000004698)
Pulvers K, Hood A (2013) The role of positive traits and pain catastrophizing in pain perception. Curr Pain Headache Rep 17(5):330. (PMID: 23512722367753410.1007/s11916-013-0330-2)
Schütze R et al (2010) Low mindfulness predicts pain catastrophizing in a fear-avoidance model of chronic pain. Pain 148(1):120–127. (PMID: 1994453410.1016/j.pain.2009.10.030)
Bishop SR et al (2004) Mindfulness: a proposed operational definition. Clin Psychol Sci Pract 11(3):230–241. (PMID: 10.1093/clipsy.bph077)
Baer RA (2011) Measuring mindfulness. Contemp Buddhism 12(1):241–261. (PMID: 10.1080/14639947.2011.564842)
Hilton L et al (2017) Mindfulness meditation for chronic pain: systematic review and meta-analysis. Ann Behav Med 51(2):199–213. (PMID: 2765891310.1007/s12160-016-9844-2)
Pleman B et al (2019) Mindfulness is associated with psychological health and moderates the impact of fibromyalgia. Clin Rheumatol 38(6):1737–1745. (PMID: 30644003654516310.1007/s10067-019-04436-1)
Senders A et al (2018) Association between pain and mindfulness in multiple sclerosis: a cross-sectional survey. Int J MS Care 20(1):28–34. (PMID: 29507540582598310.7224/1537-2073.2016-076)
Zimmaro LA et al (2020) Greater mindfulness associated with lower pain, fatigue, and psychological distress in women with metastatic breast cancer. Psychooncology 29(2):263–270. (PMID: 3150961410.1002/pon.5223)
Poulin PA et al (2016) The relationship between mindfulness, pain intensity, pain catastrophizing, depression, and quality of life among cancer survivors living with chronic neuropathic pain. Support Care Cancer 24(10):4167–4175. (PMID: 2719311610.1007/s00520-016-3243-x)
van de Poll-Franse LV et al (2011) The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47(14):2188–2194. (PMID: 2162140810.1016/j.ejca.2011.04.034)
Nederlandse Kankerregistratie. Cijfers over Kanker. [cited 2021 Sept 07]; Available from: http://www.cijfersoverkanker.nl/.
Bonhof CS et al (2021) The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients. J Cancer Surviv 15(2):190–200. (PMID: 3318583910.1007/s11764-020-00923-6)
Trompetter HR et al (2021) Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy. Support Care Cancer 30(1):95–104.
Sangha O et al (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49(2):156–163. (PMID: 1268750510.1002/art.10993)
Carlson LE, Brown KW (2005) Validation of the Mindful Attention Awareness Scale in a cancer population. J Psychosom Res 58(1):29–33. (PMID: 1577186710.1016/j.jpsychores.2004.04.366)
Postma TJ et al (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135–1139. (PMID: 1591123610.1016/j.ejca.2005.02.012)
Fayers PM et al (2001) The EORTC QLQ-C30 Scoring Manual (3rd Edn). European Organisation for Research and Treatment of Cancer: Brussels.
Smith EML et al (2019) Psychometric testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale using pooled chemotherapy-induced peripheral neuropathy outcome measures standardization and Alliance for Clinical Trials in Oncology A151408 study data. Cancer Nurs 42(3):179–189. (PMID: 2964908110.1097/NCC.0000000000000596)
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. (PMID: 688082010.1111/j.1600-0447.1983.tb09716.x)
Buysse DJ et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213. (PMID: 274877110.1016/0165-1781(89)90047-4)
Niezgoda HE, Pater JL (1993) A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res 2(5):319–325. (PMID: 813679610.1007/BF00449426)
Bonhof CS et al (2022) Symptoms of pre-treatment anxiety are associated with the development of chronic peripheral neuropathy among colorectal cancer patients. Support Care Cancer 30(6):5421–5429. (PMID: 35303166904613710.1007/s00520-022-06971-1)
Pachman DR et al (2015) Clinical course of oxaliplatin-induced neuropathy: results from the Randomized Phase III Trial N08CB (Alliance). J Clin Oncol 33(30):3416–3422. (PMID: 26282635460606010.1200/JCO.2014.58.8533)
Lee KM et al (2018) Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer. J Psychosom Res 108:14–19. (PMID: 2960232010.1016/j.jpsychores.2018.02.012)
Yoshino T et al (2019) Efficacy and long-term peripheral sensory neuropathy of 3 vs 6 Months of oxaliplatin-based adjuvant chemotherapy for colon cancer: the ACHIEVE phase 3 randomized clinical trial. JAMA Oncol 5(11):1574–1581. (PMID: 31513248674306210.1001/jamaoncol.2019.2572)
Sullivan MJL et al (2001) Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain 17(1):52–64.
Nathan HJ et al (2017) Randomized trial of the effect of mindfulness-based stress reduction on pain-related disability, pain intensity, health-related quality of life, and A1C in patients with painful diabetic peripheral neuropathy. Clin Diabetes 35(5):294–304. (PMID: 29263572573417610.2337/cd17-0077)
Veehof MM et al (2016) Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther 45(1):5–31. (PMID: 2681841310.1080/16506073.2015.1098724)
Park SB et al (2019) Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst 24(Suppl 2):S13-s25. (PMID: 31647154)
Cavaletti G et al (2010) Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 46(3):479–494. (PMID: 2004531010.1016/j.ejca.2009.12.008)
Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6(12):657–666. (PMID: 2106034110.1038/nrneurol.2010.160)
Ramsey I et al (2019) Cancer survivors who fully participate in the PROFILES registry have better health-related quality of life than those who drop out. J Cancer Surviv 13(6):829–839. (PMID: 31493162688141910.1007/s11764-019-00793-7)
Grant Information:: 2016/04981/ZONMW-91101002 Netherlands Organization for Scientific Research
Contributed Indexing:: Keywords: Anxiety symptoms; Colorectal cancer; Depressive symptoms; Mindfulness; Patient-reported outcomes; Peripheral neuropathy
Substance Nomenclature:: 0 (Antineoplastic Agents)
Entry Date(s):: Date Created: 20220828 Date Completed: 20221109 Latest Revision: 20230103
Update Code:: 20240104
PubMed Central ID:: PMC9633463
DOI:: 10.1007/s00520-022-07340-8
PMID:: 36030458
: Czasopismo naukowe

Full Text Finder

Purpose: Despite the detrimental impact of chronic (chemotherapy-induced) peripheral neuropathy PN on patients' lives, treatment options remain limited. We examined the association between mindfulness and chronic PN symptom severity and impairments in related patient-reported outcomes (PROs) among colorectal cancer (CRC) patients up to 2 years after diagnosis.
Methods: Newly diagnosed stage I-IV CRC patients from four Dutch hospitals were eligible for participation. Patients (N = 336) completed a questionnaire on mindfulness (MAAS) at 1 year after diagnosis, and questionnaires on sensory (SPN) and motor peripheral neuropathy (MPN) (EORTC QLQ-CIPN20), anxiety and depressive symptoms (HADS), sleep quality (PSQI), and fatigue (EORTC QLQ-C30) before initial treatment (baseline) and 1 and 2 years after diagnosis.
Results: At 1-year follow-up, 115 patients (34%) and 134 patients (40%), respectively, reported SPN or MPN symptoms. In multivariable regression analyses, higher mindfulness at 1-year follow-up was associated with less severe MPN and fewer anxiety and depressive symptoms, better sleep quality, and less fatigue. Of the patients with SPN or MPN at 1-year follow-up, symptoms had not returned to baseline level at 2-year follow-up in 59 (51%) and 72 (54%) patients, respectively. In this subgroup, higher mindfulness was associated with less severe SPN and fewer anxiety symptoms, depressive symptoms, and fatigue at 2-year follow-up.
Conclusion: Mindfulness was associated with less severe PN and better related PROs among CRC patients with chronic PN. More research is needed to examine the role of mindfulness in the transition from acute to chronic PN.
(© 2022. The Author(s).)

Informacja